1Tish K.The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors[J].The Oncologist,2006,11(2):96-110.
2Partridge AH,Gelber S,Peppercorn J,et al.Web-based survey of fertility issues in young women with breast cancer[J].J Clin Oncol,2004,22(145):4174-4183.
3Cosimo SD,Alimonti A,Ferretti G,et al.Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer[J].Ann Oncol,2004,15(7):1065-1071.
4Charles LS,Abram R.Side effects of adjuvant treatment of breast cancer[J].N Engl J Med,2001,344(26):1997-2005.
5Sonmezer M,Oktay K.Fertility preservation in young women undergoing breast cancer therapy[J].The Oncologist,2006,11(5):422-434.
6Jeanne AP,Michelle JN,Douglas C,et al.Incidence,time course,and determinants of menstrual bleeding after breast cancer treatment:a prospective study[J].J Clin Oncol,2006,24(7):1045-1051.
7Fornier MN,Modi S,Panageas KS,et al.Incidence of chemotheraphy-induced long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane[J].Cancer,2005,104(8):1575-1579.
8Karen HD,Deanna K.Fertility options in young breast cancer survivors:a review of the literature[J].Oncol Nurs Forum,2004,31(3):46-51.
9Meirow D.Reproduction post-chemotherapy in young cancer patients[J].Mol Cell Endocrinol,2000,169(1-2):123-132.
10Blumenfeld Z.Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure:the role of inhibin-A and -B as markers[J].Mol Cell Endocrinol,2002,187(1-2):93-105.
